mayoclinic.org - website profile
Alzheimer's treatments: What's on the horizon? - Mayo Clinic
In June 2021, the Food and Drug Administration (FDA) approved aducanumab for the treatment of some cases of Alzheimer's disease. This is the first drug approved in the United States to treat the underlying cause of Alzheimer's by targeting and removing amyloid plaques in the brain. The FDA approved the drug on the condition that further studies ...
mayoclinic.org Alternatives